SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-093250
Filing Date
2024-04-11
Accepted
2024-04-11 16:16:28
Documents
11
Period of Report
2024-05-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A d688560ddef14a.htm DEF 14A 365399
2 GRAPHIC g688560g22n44.jpg GRAPHIC 63739
3 GRAPHIC g688560page02a.jpg GRAPHIC 4493
4 GRAPHIC g688560page02b.jpg GRAPHIC 31439
5 GRAPHIC g688560page02c.jpg GRAPHIC 1624
6 GRAPHIC g688560page02d.jpg GRAPHIC 1410
7 GRAPHIC g688560page02e.jpg GRAPHIC 1402
8 GRAPHIC g688560page02f.jpg GRAPHIC 1624
9 GRAPHIC g688560page03b.jpg GRAPHIC 1061
10 GRAPHIC g688560page03c.jpg GRAPHIC 928
11 GRAPHIC g688560page05.jpg GRAPHIC 2849
  Complete submission text file 0001193125-24-093250.txt   520296
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

IRS No.: 851791125 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40128 | Film No.: 24838721
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)